Literature DB >> 28306506

Crystal Structure of the Minimal Cas9 from Campylobacter jejuni Reveals the Molecular Diversity in the CRISPR-Cas9 Systems.

Mari Yamada1, Yuto Watanabe1, Jonathan S Gootenberg2, Hisato Hirano1, F Ann Ran3, Takanori Nakane1, Ryuichiro Ishitani1, Feng Zhang4, Hiroshi Nishimasu5, Osamu Nureki6.   

Abstract

The RNA-guided endonuclease Cas9 generates a double-strand break at DNA target sites complementary to the guide RNA and has been harnessed for the development of a variety of new technologies, such as genome editing. Here, we report the crystal structures of Campylobacter jejuni Cas9 (CjCas9), one of the smallest Cas9 orthologs, in complex with an sgRNA and its target DNA. The structures provided insights into a minimal Cas9 scaffold and revealed the remarkable mechanistic diversity of the CRISPR-Cas9 systems. The CjCas9 guide RNA contains a triple-helix structure, which is distinct from known RNA triple helices, thereby expanding the natural repertoire of RNA triple helices. Furthermore, unlike the other Cas9 orthologs, CjCas9 contacts the nucleotide sequences in both the target and non-target DNA strands and recognizes the 5'-NNNVRYM-3' as the protospacer-adjacent motif. Collectively, these findings improve our mechanistic understanding of the CRISPR-Cas9 systems and may facilitate Cas9 engineering.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas system; Cas9; RNA triplex; crystal structure; protospacer adjacent motif

Mesh:

Substances:

Year:  2017        PMID: 28306506     DOI: 10.1016/j.molcel.2017.02.007

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  48 in total

1.  Balance between DNA-binding affinity and specificity enables selective recognition of longer target sequences in vivo.

Authors:  Tomoko Sunami; Hidetoshi Kono
Journal:  Protein Sci       Date:  2019-08-06       Impact factor: 6.725

Review 2.  Type II-C CRISPR-Cas9 Biology, Mechanism, and Application.

Authors:  Aamir Mir; Alireza Edraki; Jooyoung Lee; Erik J Sontheimer
Journal:  ACS Chem Biol       Date:  2017-12-20       Impact factor: 5.100

3.  CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9.

Authors:  Gaurav Dugar; Ryan T Leenay; Sara K Eisenbart; Thorsten Bischler; Belinda U Aul; Chase L Beisel; Cynthia M Sharma
Journal:  Mol Cell       Date:  2018-03-01       Impact factor: 17.970

4.  Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.

Authors:  Takashi Yamano; Bernd Zetsche; Ryuichiro Ishitani; Feng Zhang; Hiroshi Nishimasu; Osamu Nureki
Journal:  Mol Cell       Date:  2017-08-03       Impact factor: 17.970

Review 5.  The next generation of CRISPR-Cas technologies and applications.

Authors:  Adrian Pickar-Oliver; Charles A Gersbach
Journal:  Nat Rev Mol Cell Biol       Date:  2019-08       Impact factor: 94.444

6.  Directed evolution studies of a thermophilic Type II-C Cas9.

Authors:  Travis H Hand; Anuska Das; Hong Li
Journal:  Methods Enzymol       Date:  2018-12-28       Impact factor: 1.600

7.  Deoxyinosine and 7-Deaza-2-Deoxyguanosine as Carriers of Genetic Information in the DNA of Campylobacter Viruses.

Authors:  Clay S Crippen; Yan-Jiun Lee; Geoffrey Hutinet; Asif Shajahan; Jessica C Sacher; Parastoo Azadi; Valérie de Crécy-Lagard; Peter R Weigele; Christine M Szymanski
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

8.  Phosphate Lock Residues of Acidothermus cellulolyticus Cas9 Are Critical to Its Substrate Specificity.

Authors:  Travis H Hand; Anuska Das; Mitchell O Roth; Chardasia L Smith; Uriel L Jean-Baptiste; Hong Li
Journal:  ACS Synth Biol       Date:  2018-12-03       Impact factor: 5.110

Review 9.  Research on CRISPR/system in major cancers and its potential in cancer treatments.

Authors:  Z Liu; Z Liao; Y Chen; L Zhou; W Huangting; H Xiao
Journal:  Clin Transl Oncol       Date:  2020-07-15       Impact factor: 3.405

Review 10.  CRISPR RNA-guided autonomous delivery of Cas9.

Authors:  Royce A Wilkinson; Coleman Martin; Artem A Nemudryi; Blake Wiedenheft
Journal:  Nat Struct Mol Biol       Date:  2018-12-31       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.